Future destinations and social inclusion scoping review: how people cured of hepatitis C (HCV) using direct- acting antiviral drugs progress in a new HCV-free world

• Κύριοι συγγραφείς: Sarah R. Donaldson (Συγγραφέας), Andrew Radley (Συγγραφέας), John F. Dillon (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: BMC, 2022-06-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Abstract Background There has been a paradigm shift in the treatment of Hepatitis C (HCV) from the interferon-era to direct-acting antiviral (DAA) drugs. Cure of HCV for the key risk group, those with a history of injecting drug use, may provide a range of benefits to an individual's quality of...